Executive summary of the consensus document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children.
Panel of experts from the National AIDS Plan (PNS), AIDS Study Group (GeSIDA), Spanish Society of Occupational Health Safety at Work (SEMST), Spanish Society of Preventive Medicine Public Health Hygiene (SEMPSPH), Spanish Association of Specialists in Occupational Medicine (AEEMT), Spanish Society of Occupational Health in Public Administration (SESLAP), National Association of Occupational Medicine in Health (ANMTAS), Spanish Society of Paediatric Infectology (SEIP), Spanish Society for Emergency Medicine (SEMES), Study Group for Viral Hepatitis-SEIMC (GEHEP), Spanish Federation of Occupational Health Nursing (FEDEET), Polo Rodriguez R, Lozano F, González de Castro P, Jiménez MA, Miró O, Ramón Blanco J, Moreno D, Dueñas C, Muñoz Platón E, Fernández Escribano M, Sanz Sanz J, Fumaz C, Santos I, García F, Téllez MJ, González Montero R, Vals Jimenez MV, Losa J, Valle Robles ML, GESIDA GROUP, Ortega E.
Enfermedades Infecciosas Y Microbiologia Clinica. 2016; 34: 122-131. FI: 1,714 (Q3).
Executive summary of the consensus document on psychiatric and psychological aspects in adults and children with HIV infection.
Experts Panel from the Secretary of the National AIDS Plan (SPNS), Spanish Society of Psychiatry (SEP), AIDS Study Group (GeSIDA), Spanish Society of Pediatric Infectious Diseases (SEIP). Electronic address: rpo.
Enfermedades Infecciosas Y Microbiologia Clinica. 2016; 34: 54-60. FI: 1,714 (Q3).
Rhomboencephalitis and endocarditis caused by Listeria monocytogenes: an unreported association.
Tainta M, de la Riva P, Gonzalez F, Marti-Masso JF, Goenaga MA.
Revista De Neurologia. 2016; 63: 46-48. FI: 0,743 (Q4).
Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee.
Enfermedades Infecciosas Y Microbiologia Clinica. 2016; 34: 517-523. FI: 1,714 (Q3).
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee.
Enfermedades Infecciosas Y Microbiologia Clinica. 2016; 34: -. FI: 1,714 (Q3).
Validación y cumplimentación de los indicadores de calidad GESIDA en pacientes con infección por el VIH.
Riera M, Esteban H, Suarez I, Palacios R, Lozano F, Blanco JR, Valencia E, Ocampo A, Amador C, Frontera G, GESIDA Study Group of the HIV quality indicators, GESIDA Study Group of the HIV quality indicators.
Enfermedades Infecciosas Y Microbiologia Clinica. 2016; 34: 346-352. FI: 1,714 (Q3).
Presente y futuro de darunavir para el tratamiento de la infección por virus de la inmunodeficiencia humana.
Iribarren JA.
Enfermedades Infecciosas Y Microbiologia Clinica. 2016; 34 Suppl 1: 34-40. FI: 1,714 (Q3).
Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection.
Alejos B, Hernando V, Iribarren J, Gonzalez-García J, Hernando A, Santos J, Asensi V, Gomez-Berrocal A, Del Amo J, Jarrin I, CoRIS (Cohort of the Spanish Network on HIVAIDS Research).
Medicine. 2016; 95: -. FI: 1,803 (Q2).
Transmission dynamics of HIV-1 subtype B in the Basque Country, Spain.
Patiño-Galindo JA, Thomson MM, Pérez-Álvarez L, Delgado E, Cuevas MT, Fernández-García A, Nájera R, Iribarren JA, Cilla G, López-Soria L, Lezaun MJ, Cisterna R, González-Candelas F, Agud, JM, Aldamiz M, Ayensa C, Barroso J, Michaus L, Pérez-Ortolá R, de Santiago PJJH, Andia A, Labora A, Echevarría J, Serrano-Bengoechea E, de Zumarraga H, Vizcaya, BMA, de Galdákano, H., López de Goicoechea M, Mayo J, de Cruces H, Aguirrebengoa K, Soria L, Goikoetxea J, Montejo M, Bereciartura E, de Basurto H, Baraia J, Ezpeleta C, Ferrero O, Ibarra S, Imaz, M., Muñoz-Sánchez J, Santamaría JM, Sota M, Zubero Z, San Eloy H, Lizarraga M, Silvariño R.
Infection Genetics And Evolution. 2016; 40: 91-97. FI: 2,885 (Q2).
Tropheryma whipplei endocarditis in Spain: Case reports of 17 prospective cases.
Garcia-Alvarez L, Sanz MM, Marin M, Farinas MC, Montejo M, Goikoetxea J, Rodriguez R, de Alarcon A, Almela M, Fernandez-Hidalgo N, Alonso MM, Goenaga MA, Navas E, Vicioso L, Oteo JA, Spanish Collaboration Endocarditis.
Medicine. 2016; 95: -. FI: 1,803 (Q2).
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
Podlekareva DN, Efsen AM, Schultze A, Post FA, Skrahina AM, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Miro JM, Vassilenko A, Girardi E, Bruyand M, Obel N, Lundgren JD, Mocroft A, Kirk O, TB:HIV study group in EuroCoord.
Lancet Hiv. 2016; 3: 120-131. FI: 9,842 (Q1).
Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
Geskus RB, González C, Torres M, Del Romero J, Viciana P, Masiá M, Blanco JR, Iribarren M, De Sanjosé S, Hernández-Novoa B, Ortiz M, Del Amo J, CoRIS-HPV Study Group.
Aids. 2016; 30: 37-44. FI: 5,003 (Q1).
Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.
Laguno M, Von Wichmann MA, Van den Eynde E, Navarro J, Cifuentes C, Murillas J, Veloso S, Martínez-Rebollar M, Guardiola JM, Jou A, Gómez-Sirvent JL, Cervantes M, Pineda JA, López-Calvo S, Carrero A, Montes ML, Deig E, Tapiz A, Ruiz-Mesa JD, Cruceta A, de Lazzari E, Mallolas J.
Int J Infect Dis. 2016; 53: 46-51. FI: 2,532 (Q2).
Rate and predictors of progression in elite and viremic HIV-1 controllers.
Leon A, Perez I, Ruiz-Mateos E, Benito JM, Leal M, Lopez-Galindez C, Rallon N, Alcami J, Lopez-Aldeguer J, Viciana P, Rodriguez C, Grau E, Iribarren J, Gatell JM, Garcia F, EC and Immune Pathogenesis Working group of the Spanish AIDS Research Network.
Aids. 2016; 30: 1209-1220. FI: 5,003 (Q1).